Heartflow CMO exercises options, sells 9,219 shares
Heartflow, Inc. Chief Medical Officer Campbell Rogers reported an option exercise and related share sale in Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Heartflow, Inc. Chief Medical Officer Campbell Rogers reported an option exercise and related share sale in Common Stock. On May 18, 2026, he exercised stock options to acquire 9,219 shares at $19.00 per share, then sold 9,219 shares in an open-market transaction at $28.34 per share.
The filing shows he now holds 78,731 Common Stock shares directly. In addition, multiple trusts associated with him and his spouse report indirect holdings, including 50,754 shares by The Campbell Rogers Revocable Trust and 26,012 shares by a spouse’s trust. The footnotes state the option exercise and sale were carried out under a pre-arranged Rule 10b5-1 Trading Plan adopted on December 12, 2025.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,219 shares ($86K approx. pre-tax spread)
Exercise and Sale
7 txns
Insider
Rogers Campbell
Role
Chief Medical Officer
Sold
9,219 shs ($261K)
Approx. gross sale proceeds
$261K
Approx. exercise cost
$175K
Approx. pre-tax spread
$86K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options | 9,219 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,219 | $19.00 | $175K |
| Sale | Common Stock | 9,219 | $28.34 | $261K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options — 101,410 contracts (Direct);
Common Stock — 78,731 shares (Direct);
Common Stock — 22,615 shares (Indirect, By Campbell Rogers 2019 Irrevocable Trust);
Common Stock — 46,159 shares (Indirect, By CR Asset Protection Trust of 2023);
Common Stock — 26,012 shares (Indirect, By Spouse's Trust);
Common Stock — 50,754 shares (Indirect, By The Campbell Rogers Revocable Trust)
Footnotes (2)
- F1. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
- F2. The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.
Key Figures
Shares sold: 9,219 shares
Sale price: $28.34 per share
Options exercised: 9,219 options
+5 more
8 metrics
Shares sold
9,219 shares
Common Stock sold in open-market transaction on May 18, 2026
Sale price
$28.34 per share
Price for 9,219 Common Stock shares sold
Options exercised
9,219 options
Stock options exercised into Common Stock on May 18, 2026
Exercise price
$19.00 per share
Exercise or conversion price of stock options
Direct shares after transaction
78,731 shares
Common Stock directly held by Rogers following transactions
Revocable trust holdings
50,754 shares
Common Stock held by The Campbell Rogers Revocable Trust
Spouse’s trust holdings
26,012 shares
Common Stock held by spouse’s trust
Option expiration
August 7, 2035
Expiration date for the reported stock options
Key Terms
Rule 10b5-1 Trading Plan, open-market sale, Stock Options, derivative security, +1 more
5 terms
Rule 10b5-1 Trading Plan regulatory
"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Options financial
""security_title": "Stock Options""
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
indirect ownership financial
""ownership_type": "indirect""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Heartflow (HTFL) report for Campbell Rogers?
Heartflow’s Chief Medical Officer Campbell Rogers exercised stock options and sold shares. He exercised 9,219 options at $19.00 per share and sold 9,219 Common Stock shares at $28.34 per share, all recorded on May 18, 2026.
What stock options did Campbell Rogers exercise in this Heartflow (HTFL) Form 4?
Rogers exercised 9,219 stock options for Heartflow Common Stock at an exercise price of $19.00 per share. These options relate to a grant that vests in monthly installments until August 7, 2029, conditioned on continued service with the company.
Were Campbell Rogers’ Heartflow (HTFL) trades made under a Rule 10b5-1 plan?
Yes. A footnote explains the option exercise and subsequent sale were executed under a Rule 10b5-1 Trading Plan adopted by Rogers on December 12, 2025. Such plans pre-schedule trades, making their timing more routine and less discretionary.
What indirect Heartflow (HTFL) holdings are reported for Campbell Rogers?
The Form 4 lists several indirect Heartflow holdings. These include 50,754 Common Stock shares held by The Campbell Rogers Revocable Trust, 26,012 shares by a spouse’s trust, 46,159 shares by the CR Asset Protection Trust of 2023, and 22,615 shares by a 2019 irrevocable trust.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates